You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: August 2021 to July 2025

AbstractFullPdf
Aug 202112581265383
Sep 2021567569460
Oct 2021501501154
Nov 2021426427141
Dec 2021383385105
Jan 202235236896
Feb 2022392398119
Mar 2022264270174
Apr 2022241255144
May 2022241245174
Jun 2022299312142
Jul 2022468474130
Aug 2022552562155
Sep 2022590606156
Oct 2022628632132
Nov 2022430432153
Dec 2022348352111
Jan 202333833897
Feb 2023419426121
Mar 2023495497175
Apr 2023402404144
May 2023384385114
Jun 2023394395113
Jul 2023513517115
Aug 202336736793
Sep 202336636682
Oct 202335936292
Nov 2023373373127
Dec 2023403404140
Jan 2024364364145
Feb 2024332332157
Mar 2024391393217
Apr 2024343345160
May 2024308308162
Jun 2024264265106
Jul 2024342343153
Aug 202422722687
Sep 2024219219150
Oct 2024304304157
Nov 2024325326138
Dec 2024283288103
Jan 2025289289123
Feb 2025199201109
Mar 2025272272120
Apr 2025268268124
May 2025284284216
Jun 202519119265
Jul 2025110
Total17959181076834